An optogenetic toolbox designed for primates

Department of Bioengineering, Stanford University, Stanford, California, USA.
Nature Neuroscience (Impact Factor: 16.1). 01/2011; 14(3):387-97. DOI: 10.1038/nn.2749
Source: PubMed


Optogenetics is a technique for controlling subpopulations of neurons in the intact brain using light. This technique has the potential to enhance basic systems neuroscience research and to inform the mechanisms and treatment of brain injury and disease. Before launching large-scale primate studies, the method needs to be further characterized and adapted for use in the primate brain. We assessed the safety and efficiency of two viral vector systems (lentivirus and adeno-associated virus), two human promoters (human synapsin (hSyn) and human thymocyte-1 (hThy-1)) and three excitatory and inhibitory mammalian codon-optimized opsins (channelrhodopsin-2, enhanced Natronomonas pharaonis halorhodopsin and the step-function opsin), which we characterized electrophysiologically, histologically and behaviorally in rhesus monkeys (Macaca mulatta). We also introduced a new device for measuring in vivo fluorescence over time, allowing minimally invasive assessment of construct expression in the intact brain. We present a set of optogenetic tools designed for optogenetic experiments in the non-human primate brain.

Download full-text


Available from: Charu Ramakrishnan
  • Source
    • "Long-Term Two-Photon Calcium Imaging of Multiple Neurons Having succeeded with the initial imaging, we went on to test whether long-term imaging experiments were possible. It has been reported that transgene expression from AAV gradually increases over a period of up to 2 months (Diester et al., 2011), and this could result in toxicity in experiments that last for several weeks or months (Chen et al., 2013b; Tian et al., 2009). In this regard , the AAV TET-inducible system offers the advantage of controlling transgene expression by Dox administration. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Two-photon imaging with genetically encoded calcium indicators (GECIs) enables long-term observation of neuronal activity in vivo. However, there are very few studies of GECIs in primates. Here, we report a method for long-term imaging of a GECI, GCaMP6f, expressed from adeno-associated virus vectors in cortical neurons of the adult common marmoset (Callithrix jacchus), a small New World primate. We used a tetracycline-inducible expression system to robustly amplify neuronal GCaMP6f expression and up- and downregulate it for more than 100 days. We succeeded in monitoring spontaneous activity not only from hundreds of neurons three-dimensionally distributed in layers 2 and 3 but also from single dendrites and axons in layer 1. Furthermore, we detected selective activities from somata, dendrites, and axons in the somatosensory cortex responding to specific tactile stimuli. Our results provide a way to investigate the organization and plasticity of cortical microcircuits at subcellular resolution in non-human primates.
    Full-text · Article · Nov 2015 · Cell Reports
    • "Interestingly, these approaches hold the promise to widen the range of model species in which the underlying pathophysiology of sleep disorders can be investigated. The application of these technologies in NHP in particular [155] [156] is expected to yield significant insight given the similarities of their sleep organization with that of humans (Box 1). However, our quest for an animal model with a humanized phenocopy of PD associated sleep syndrome should not distract us from making use of our current models to learn more about the fundamental pathophysiology of some aspects of sleep alterations in PD. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Parkinson disease is one of the neurodegenerative diseases that benefited the most from the use of non-human models. Consequently, significant advances have been made in the symptomatic treatments of the motor aspects of the disease. Unfortunately, this translational success has been tempered by the recognition of the debilitating aspect of multiple non-motor symptoms of the illness. Alterations of the sleep/wakefulness behavior experienced as insomnia, excessive daytime sleepiness, sleep/wake cycle fragmentation and REM sleep behavior disorder are among the non-motor symptoms that predate motor alterations and inevitably worsen over disease progression. The absence of adequate humanized animal models with the perfect phenocopy of these sleep alterations contribute undoubtedly to the lack of efficient therapies for these non-motor complications. In the context of developing efficient translational therapies, we provide an overview of the strengths and limitations of the various currently available models to replicate sleep alterations of Parkinson's disease. Our investigation reveals that although these models replicate dopaminergic deficiency and related parkinsonism, they rarely display a combination of sleep fragmentation and excessive daytime sleepiness and never REM sleep behavior disorder. In this light, we critically discuss the construct, face and predictive validities of both rodent and non-human primate animals to model the main sleep abnormalities experienced by patients with PD. We conclude by highlighting the need of integrating a network-based perspective in our modeling approach of such complex syndrome in order to celebrate valid translational models. Copyright © 2015 Elsevier Ltd. All rights reserved.
    No preview · Article · Feb 2015 · Sleep Medicine Reviews
  • Source
    • "The use of optogenetics in humans for treatment of neurological disorders has been extensively discussed (Peled, 2011; Kumar et al., 2013; Touriño et al., 2013), however, clinical application of optogenetics technology is, to our knowledge, currently not feasible. Extending optogenetic methods to species beyond rodents has only been stably, safely and efficiently applied in the rhesus macaque, a non-human primate (Han et al., 2009; Diester et al., 2011; Han et al., 2011; Cavanaugh et al., 2012; Gerits et al., 2012; Jazayeri et al., 2012). Further studies and clinical trials will be required to safely express and photostimulate opsins in the human brain. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The medial prefrontal cortex (mPFC) is critically involved in numerous cognitive functions, including attention, inhibitory control, habit formation, working memory and long-term memory. Moreover, through its dense interconnectivity with subcortical regions (e.g., thalamus, striatum, amygdala and hippocampus), the mPFC is thought to exert top-down executive control over the processing of aversive and appetitive stimuli. Because the mPFC has been implicated in the processing of a wide range of cognitive and emotional stimuli, it is thought to function as a central hub in the brain circuitry mediating symptoms of psychiatric disorders. New optogenetics technology enables anatomical and functional dissection of mPFC circuitry with unprecedented spatial and temporal resolution. This provides important novel insights in the contribution of specific neuronal subpopulations and their connectivity to mPFC function in health and disease states. In this review, we present the current knowledge obtained with optogenetic methods concerning mPFC function and dysfunction and integrate this with findings from traditional intervention approaches used to investigate the mPFC circuitry in animal models of cognitive processing and psychiatric disorders.
    Full-text · Article · Dec 2014 · Frontiers in Systems Neuroscience
Show more